[{"id":"3eb84e3a-596a-4eb0-a2c6-ca4c30c42738","acronym":"NCI-2018-01441","url":"https://clinicaltrials.gov/study/NCT03608631","created_at":"2021-01-18T17:44:21.049Z","updated_at":"2024-07-02T16:35:10.185Z","phase":"Phase 1","brief_title":"iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation","source_id_and_acronym":"NCT03608631 - NCI-2018-01441","lead_sponsor":"M.D. Anderson Cancer Center","biomarkers":" KRAS","pipe":" | ","alterations":" KRAS mutation • KRAS G12D • KRAS G12","tags":["KRAS"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e KRAS mutation • KRAS G12D • KRAS G12"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Undisclosed MSC-derived Exosomes with KrasG12D siRNA"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 15","initiation":"Initiation: 01/27/2021","start_date":" 01/27/2021","primary_txt":" Primary completion: 04/30/2025","primary_completion_date":" 04/30/2025","study_txt":" Completion: 04/30/2025","study_completion_date":" 04/30/2025","last_update_posted":"2024-04-11"}]